AbbVie execs say biosimilar competition to Humira is eroding profits, ‘but we have a plan’
April 25, 2019 at 13:43 PM EDT
AbbVie executives sought to reassure investors during a Wednesday call that its pipeline will more than plug up any holes that biosimilars might leave.